584 related articles for article (PubMed ID: 22743059)
1. Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.
Ji W; Li Y; Wan T; Wang J; Zhang H; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2271-9. PubMed ID: 22743059
[TBL] [Abstract][Full Text] [Related]
2. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.
Zhang H; Zhang R; Luo Y; D'Alessio A; Pober JS; Min W
J Biol Chem; 2004 Oct; 279(43):44955-65. PubMed ID: 15310755
[TBL] [Abstract][Full Text] [Related]
3. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
Ruspi G; Schmidt EM; McCann F; Feldmann M; Williams RO; Stoop AA; Dean JL
Cell Signal; 2014 Apr; 26(4):683-90. PubMed ID: 24378531
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site.
Grech AP; Gardam S; Chan T; Quinn R; Gonzales R; Basten A; Brink R
J Biol Chem; 2005 Sep; 280(36):31572-81. PubMed ID: 16020544
[TBL] [Abstract][Full Text] [Related]
5. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.
Hamid T; Gu Y; Ortines RV; Bhattacharya C; Wang G; Xuan YT; Prabhu SD
Circulation; 2009 Mar; 119(10):1386-97. PubMed ID: 19255345
[TBL] [Abstract][Full Text] [Related]
6. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
Twu YC; Gold MR; Teh HS
Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
[TBL] [Abstract][Full Text] [Related]
7. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.
Zhang H; Zhang H; Lin Y; Li J; Pober JS; Min W
J Biol Chem; 2007 May; 282(20):14788-96. PubMed ID: 17389591
[TBL] [Abstract][Full Text] [Related]
8. Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression.
Chandrasekharan UM; Dechert L; Davidson UI; Waitkus M; Mavrakis L; Lyons K; Beach JR; Li X; Egelhoff TT; Fox PL; DiCorleto PE
Sci Signal; 2013 Jul; 6(284):ra60. PubMed ID: 23861542
[TBL] [Abstract][Full Text] [Related]
9. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
Borghi A; Verstrepen L; Beyaert R
Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
[TBL] [Abstract][Full Text] [Related]
10. Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation.
Won M; Park KA; Byun HS; Sohn KC; Kim YR; Jeon J; Hong JH; Park J; Seok JH; Kim JM; Yoon WH; Jang IS; Shen HM; Liu ZG; Hur GM
Cell Death Differ; 2010 Dec; 17(12):1830-41. PubMed ID: 20448643
[TBL] [Abstract][Full Text] [Related]
11. TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2.
Cabal-Hierro L; Rodríguez M; Artime N; Iglesias J; Ugarte L; Prado MA; Lazo PS
Cell Signal; 2014 Dec; 26(12):2658-66. PubMed ID: 25152365
[TBL] [Abstract][Full Text] [Related]
12. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
[TBL] [Abstract][Full Text] [Related]
13. TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells.
Zhou Z; Connell MC; MacEwan DJ
Cell Signal; 2007 Jun; 19(6):1238-48. PubMed ID: 17292586
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2.
Rodríguez M; Cabal-Hierro L; Carcedo MT; Iglesias JM; Artime N; Darnay BG; Lazo PS
J Biol Chem; 2011 Jul; 286(26):22814-24. PubMed ID: 21558270
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor receptor expression and signaling in renal cell carcinoma.
Al-Lamki RS; Sadler TJ; Wang J; Reid MJ; Warren AY; Movassagh M; Lu W; Mills IG; Neal DE; Burge J; Vandenebeele P; Pober JS; Bradley JR
Am J Pathol; 2010 Aug; 177(2):943-54. PubMed ID: 20566746
[TBL] [Abstract][Full Text] [Related]
16. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
Munroe ME; Bishop GA
J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway.
Marchetti L; Klein M; Schlett K; Pfizenmaier K; Eisel UL
J Biol Chem; 2004 Jul; 279(31):32869-81. PubMed ID: 15155767
[TBL] [Abstract][Full Text] [Related]
18. A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1.
Cabal-Hierro L; Artime N; Iglesias J; Prado MA; Ugarte-Gil L; Casado P; Fernández-García B; Darnay BG; Lazo PS
Oncotarget; 2014 Jan; 5(1):224-36. PubMed ID: 24318359
[TBL] [Abstract][Full Text] [Related]
19. The involvement of β-actin in the signaling of transmembrane TNF-α-mediated cytotoxicity.
Chen H; Xiao L; Zhang H; Liu N; Liu T; Liu L; Hu X; Yan D; Yang K; Yin B; Wang J; Li Q; Li Z
J Leukoc Biol; 2011 Jun; 89(6):917-26. PubMed ID: 21402772
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.
Cheng N; Chen J
J Biol Chem; 2001 Apr; 276(17):13771-7. PubMed ID: 11278471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
